Navigation Links
Sonic Innovations Not Included in Adverse Jury Verdict
Date:2/13/2008

Patent Infringement Judgment Against Widex and William Demant Companies

SALT LAKE CITY, Feb. 13 /PRNewswire-FirstCall/ -- Sonic Innovations, Inc. (Nasdaq: SNCI), a leading producer of advanced digital hearing aids, issues this statement to clarify confusion raised by a number of press releases related to a jury award of $31 million in a patent infringement action captioned Energy Transportation Group, Inc. v. Sonic Innovations, Inc., et al. While this action named numerous defendants, Sonic Innovations was no longer a party when the case went to trial, and likewise was not a part of the jury award.

Prior to trial, Sonic Innovations entered into a settlement agreement with Energy Transportation Group, Inc. ("ETG")-and was dismissed from this lawsuit. The recently announced jury verdict in this case was against other defendants-and had no financial impact on Sonic Innovations.

As previously disclosed in the Form 8-K filed October 17, 2007, Sonic Innovations announced it incurred $973,000 for settlement costs and legal fees in excess of previously recorded reserves related to the litigation during the third quarter of 2007. As a result of this settlement, Sonic has realized significant savings in legal fees and was excluded from the adverse jury verdict.

The jury verdict in this action, entered on February 4, 2008, awarded $31 million in damages against the remaining two defendants in the lawsuit, known as the Widex and Demant defendants. The Widex defendants are Widex A/S and Widex Hearing Aid Co., Inc. The Demant defendants are William Demant Holding A/S, WDH Inc., Oticon A/S, Oticon Inc., Bernafon AG and Bernfon, LLC.

Sonic Innovations designs, develops, manufactures and markets advanced digital hearing ai
'/>"/>

SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007
2. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
3. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
4. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
5. Young Innovations, Inc. Provides Fourth Quarter Conference Call Details
6. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
7. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
8. EMS Magazine Announces Top Product Innovations for 2007
9. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
10. Inverness Medical Innovations Announces Closing of Public Offering
11. Inverness Medical Innovations Acquires Alere Medical
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2Common mental disorders may be more common than we think 56851 1Common mental disorders may be more common than we think 56851 2Dividing cells feel their way out of warp 9878 1Dividing cells feel their way out of warp 9878 2Carbon nanotubes could make efficient solar cells 9875 1Carbon nanotubes could make efficient solar cells 9875 2